A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes
Clinical trial NCT05831644 · COMPLETED
Trial details
- NCT number
- NCT05831644
- Sponsor
- Vicore Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2023-06-16
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.